Company intelligence / Profile preview

Antibodies.com

Cambridge, England, United Kingdomantibodies.com ↗

Ownership: Private
Development stage: Commercial

Overview

Antibodies.com is an active commercial supplier of high-quality antibodies, proteins, peptides, and ELISA kits to support life science research. The company does not have clinical programs or drug development results as it focuses on providing reagents and tools for academic and industry researchers.

Modalities: AntibodyProteinPeptidesELISA kit (Immunoassay)
Industry: Non-Drug Biotech

Partnerships

Cactus Communications ("CACTUS") – partnership to support effective science communications and accelerate manuscript publication in the life sciences sector.

Beyond the preview

Go deeper on Antibodies.com.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antibodies.com.

Explore the full profile